Clinical trial

Catalysing the Containment of COVID-19

NCT04523090

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2020-08-27

PhasePHASE2 / PHASE3

Study timeline

Study start (actual)2020-08-27Date precision: day

Registry last updated2022-08-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

COVID-19unresolved

Interventions

NitazoxanideDRUG · verified · RxNorm: nitazoxanide

Sponsors & collaborators

University of Cape Townlead sponsor

Medical Research Council, South Africacollaborator

Aurum Institutecollaborator

National Institutes of Health (NIH)collaborator

Texas Tech University Health Sciences Centercollaborator

University of KwaZulucollaborator

Perinatal HIV Research Unit of the University of the Witswatersrandcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04523090 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.